Nyxoah SA
Develops hypoglossal neurostimulation therapy for Obstructive Sleep Apnea (OSA).
NYXH | BR
Overview
Corporate Details
- ISIN(s):
- BE0974358906
- LEI:
- 5493002O1ESKZ18OXR80
- Country:
- Belgium
- Address:
- Rue Edouard Belin 12, 1435 Mont-Saint-Guibert
- Website:
- https://www.nyxoah.com/
- Sector:
- Manufacturing
Description
Nyxoah SA is a medical technology company focused on the development and commercialization of solutions for Obstructive Sleep Apnea (OSA). The company's lead product is the Genio® system, a hypoglossal neurostimulation (HNS) therapy designed for patients with moderate to severe OSA. The system features a patient-centered, leadless, and battery-free implantable stimulator. It functions by providing bilateral stimulation to the hypoglossal nerve, which controls tongue muscles, to maintain an open airway during sleep.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-05-22 22:05 |
Special board report - Art 7_197, 7_191, 7_193 (FR).pdf
|
French | 329.7 KB | ||
| 2024-05-22 22:05 |
1. ENGLISH_Financing Launch Press Release - May 2024.pdf
|
English | 115.7 KB | ||
| 2024-05-22 22:05 |
1. FRENCH_Financing Launch Press Release - May 2024.pdf
|
French | 142.4 KB | ||
| 2024-05-14 22:05 |
Nyxoah Q1 2024 FS - ENG (FINAL).pdf
|
English | 667.3 KB | ||
| 2024-05-14 22:05 |
Nyxoah Q1 2024 FS - FR (FINAL).pdf
|
French | 674.5 KB | ||
| 2024-05-14 22:05 |
ENGLISH_Q1 2024 Earnings PR.pdf
|
English | 303.2 KB | ||
| 2024-05-14 22:05 |
FRENCH_Q1 2024 Earnings PR.pdf
|
French | 309.3 KB | ||
| 2024-05-10 07:00 |
DOC 15 - Nyxoah - Auditor report statutory annual accounts 2023 (ENG).pdf
|
English | 125.8 KB | ||
| 2024-05-10 07:00 |
DOC 13 - Nyxoah - Board report statutory annual accounts 2023 (ENG).pdf
|
English | 1.1 MB | ||
| 2024-05-10 07:00 |
DOC 04 - Nyxoah - ASM 2024 - Proxy form (ENG FR).pdf
|
French | 347.5 KB | ||
| 2024-05-10 07:00 |
DOC 14 - Nyxoah - Board report statutory annual accounts 2023 (FR).pdf
|
French | 1.2 MB | ||
| 2024-05-10 07:00 |
DOC 16 - Nyxoah - Auditor report statutory annual accounts 2023 (FR).pdf
|
French | 149.0 KB | ||
| 2024-05-10 07:00 |
DOC 12 - Nyxoah - Statutory annual account 2023 (FR).PDF
|
French | 885.5 KB | ||
| 2024-05-10 07:00 |
DOC 07 - Nyxoah - ESM 2024 - Proxy form (ENG FR).pdf
|
French | 298.2 KB | ||
| 2024-05-10 07:00 |
DOC 17 - Nyxoah - Remuneration policy (submitted to ASM for approval).pdf
|
English | 269.1 KB |
Automate Your Workflow. Get a real-time feed of all Nyxoah SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Nyxoah SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Nyxoah SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-11-19 | Laurette Renard | Close relation | Sell | 5,000 | 39,000.00 EUR |
| 2024-09-05 | Hambrecht Jürgen | Board | Sell | 980,000 | 6,840,400.00 EUR |
| 2024-09-05 | JH Capital GmbH | Close relation | Buy | 980,000 | 6,840,400.00 EUR |
| 2024-01-25 | Tompkins Patrick | Executive member | Buy | 2,000 | 18,020.00 USD |
| 2023-12-28 | Onkelinx Bruno | Executive member | Buy | 470 | 2,035.10 EUR |
| 2023-08-18 | Moreau Loïc | Executive member | Buy | 6,427 | 48,416.52 EUR |
| 2023-08-14 | Moreau Loïc | Executive member | Buy | 3,800 | 28,697.60 EUR |
| 2023-08-11 | Moreau Loïc | Executive member | Buy | 3,000 | 21,957.60 EUR |
| 2023-07-04 | Wildman Ventures LLC | Board | Buy | 25,000 | N/A |
| 2023-07-02 | Gianello Pierre | Board | Buy | 25,000 | N/A |
Peer Companies
